MELK and PKMYT1 (a dark kinase gene) have been identified as promising therapeutic targets in multiple cancers, such as the brain, colorectal, breast, ovarian, and esophageal cancers, respectively [33,34,35]. The gene discussed is MELK; the disease is esophageal cancer.